Division of Drug Discovery Research, Korea Research Institute of Chemical Technology, Yuseong-gu, Daejeon 305-343, Republic of Korea.
Bioorg Med Chem Lett. 2013 Mar 15;23(6):1736-9. doi: 10.1016/j.bmcl.2013.01.053. Epub 2013 Jan 24.
The discovery and optimization of novel pyrrolo[3,4-b]pyridin-7(6H)-one MCH-R1 antagonists are described. A systematic SAR study probing the effects of aryl-, benzyl- and arylthio-substituents at the 2-position of the pyrrolo[3,4-b]pyridin-7(6H)-ones led to identification of the 2-[(4-fluorophenyl)thio] derivative 7b as a highly potent MCH-R1 antagonist. This compound also has favorable pharmacokinetic properties along with a high metabolic stability and a minimal impact on CYP isoforms and hERG.
新型吡咯并[3,4-b]吡啶-7(6H)-酮 MCH-R1 拮抗剂的发现和优化。通过对吡咯并[3,4-b]吡啶-7(6H)-酮 2-位芳基、苄基和芳硫取代基的系统构效关系研究,确定了 2-[(4-氟苯基)硫基]衍生物 7b 为一种高活性的 MCH-R1 拮抗剂。该化合物还具有良好的药代动力学特性,代谢稳定性高,对 CYP 同工酶和 hERG 的影响极小。